14 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Inhibitors of Influenza Virus Polymerase Acidic (PA) Endonuclease: Contemporary Developments and Perspectives.
Shandong University
Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Protein-Protein Interaction as a Target for Next-Generation Anti-influenza Therapeutics.
University Of Perugia
Structural and computational study on inhibitory compounds for endonuclease activity of influenza virus polymerase.
Chiba University
Inhibition of cap (m7GpppXm)-dependent endonuclease of influenza virus by 4-substituted 2,4-dioxobutanoic acid compounds.
Merck Research Laboratories
Synthesis of natural flutimide and analogous fully substituted pyrazine-2,6-diones, endonuclease inhibitors of influenza virus.
Merck Research Laboratories
Anti-influenza virus activities of 4-substituted 2,4-dioxobutanoic acid inhibitors.
Merck Research Laboratories
Identification of influenza endonuclease inhibitors using a novel fluorescence polarization assay.
University Of Tennessee Health Science Center
Tetramic and tetronic acids: an update on new derivatives and biological aspects.
University Of Bayreuth
Synthesis and characterization of 1,2,4-triazolo[1,5-a]pyrimidine-2-carboxamide-based compounds targeting the PA-PB1 interface of influenza A virus polymerase.
University Of Perugia
Use of a pharmacophore model to discover a new class of influenza endonuclease inhibitors.
Roche Discovery Welwyn
Fragment-Based Identification of Influenza Endonuclease Inhibitors.
University Of California San Diego
SAR Exploration of Tight-Binding Inhibitors of Influenza Virus PA Endonuclease.
University Of California
Synthesis and SAR Study of Carbamoyl Pyridone Bicycle Derivatives as Potent Inhibitors of Influenza Cap-dependent Endonuclease.
Shionogi